Bayesian Capital Management, LP / BSX
Bayesian Capital Management, LP’s Boston Scientific Corp Position
Does Bayesian Capital Management, LP own Boston Scientific Corp (BSX)? Yes — 23.6K shares worth $1M (+1.81% of its 13F portfolio) as of Q1 2026, down from 55.2K shares the prior filed quarter.
Position Value
$1M
Q1 2026
Shares
23.6K
% of Portfolio
+1.81%
Quarters Held
23
currently held
Position History BSX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 23.6K | $1M | +1.81% |
| Q3 2025 | 55.2K | $5M | +1.10% |
| Q1 2025 | 4.9K | $494,312 | +0.08% |
| Q4 2024 | 13.1K | $1M | +0.14% |
| Q3 2024 | 36.8K | $3M | +0.36% |
| Q2 2024 | 43.3K | $3M | +0.38% |
| Q1 2024 | 44.2K | $3M | +0.29% |
| Q4 2023 | 45.4K | $3M | +0.28% |
| Q3 2023 | 23.4K | $1M | +0.14% |
| Q2 2023 | 10.6K | $573,354 | +0.06% |
| Q1 2023 | 85.8K | $4M | +0.53% |
| Q4 2022 | 25.1K | $1M | +0.17% |
| Q2 2022 | 53.8K | $2M | +0.37% |
| Q1 2022 | 50.7K | $2M | +0.34% |
| Q4 2021 | 97.6K | $4M | +1.31% |
| Q3 2021 | 41.4K | $2M | +0.52% |
| Q2 2021 | 13.8K | $590,000 | +0.15% |
| Q1 2021 | 38.4K | $1M | +0.34% |
| Q4 2020 | 132.3K | $5M | +1.24% |
| Q3 2020 | 51.6K | $2M | +0.48% |
| Q2 2020 | 41.9K | $1M | +0.32% |
| Q1 2020 | 34.6K | $1M | +0.24% |
| Q4 2019 | 13.9K | $629,000 | +0.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bayesian Capital Management, LP’s full portfolio or all institutional holders of BSX.